EMEA (Europe, Middle East and Africa) Anticoagulants Market 2017 Forecast to 2022

December 2017 | 115 pages | ID: E96545CA488EN
GlobalInfoResearch

Abstracts

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Scope of the Report:

This report focuses on the Anticoagulants in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Sanofi
• Bayer
• Boehringer Ingelheim
• Johnson & Johnson
• Genentech (Roche)
• AstraZeneca
• Bristol-Myers Squibb
• Aspen
• Lilly
• Otsuka
• Pfizer
• Daiichi Sankyo
• The Medicines Company

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

• Platelet aggregation inhibitors (PAI)
• Low-molecular-weight Heparin (LMWH)
• Direct thrombin inhibitor (DTI)
• Direct factor Xa inhibitors (DFXa)
• Vitamin K antagonists (VKA)
• Others

Market Segment by Applications, can be divided into

• VTE
• ACS/MI
• AF
• Other

There are 13 Chapters to deeply display the EMEA Anticoagulants market.

Chapter 1, to describe Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anticoagulants, with sales, revenue, and price of Anticoagulants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Anticoagulants, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Anticoagulants research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Anticoagulants Introduction
1.2 Market Analysis by Type
  1.2.1 Platelet aggregation inhibitors (PAI)
  1.2.2 Low-molecular-weight Heparin (LMWH)
  1.2.3 Direct thrombin inhibitor (DTI)
  1.2.4 Direct factor Xa inhibitors (DFXa)
  1.2.5 Vitamin K antagonists (VKA)
  1.2.6 Others
1.3 Market Analysis by Applications
  1.3.1 VTE
  1.3.2 ACS/MI
  1.3.3 AF
  1.3.4 Other
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Business Overview
  2.1.2 Anticoagulants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
  2.2.1 Business Overview
  2.2.2 Anticoagulants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
  2.3.1 Business Overview
  2.3.2 Anticoagulants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
  2.4.1 Business Overview
  2.4.2 Anticoagulants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genentech (Roche)
  2.5.1 Business Overview
  2.5.2 Anticoagulants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
  2.6.1 Business Overview
  2.6.2 Anticoagulants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
  2.7.1 Business Overview
  2.7.2 Anticoagulants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Aspen
  2.8.1 Business Overview
  2.8.2 Anticoagulants Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lilly
  2.9.1 Business Overview
  2.9.2 Anticoagulants Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Otsuka
  2.10.1 Business Overview
  2.10.2 Anticoagulants Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer
  2.11.1 Business Overview
  2.11.2 Anticoagulants Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Daiichi Sankyo
  2.12.1 Business Overview
  2.12.2 Anticoagulants Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 The Medicines Company
  2.13.1 Business Overview
  2.13.2 Anticoagulants Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA ANTICOAGULANTS MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Anticoagulants Sales and Market Share by Manufacturer
3.2 EMEA Anticoagulants Revenue and Market Share by Manufacturer
3.3 EMEA Anticoagulants Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Anticoagulants Manufacturer Market Share
  3.4.2 Top 5 Anticoagulants Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA ANTICOAGULANTS MARKET ANALYSIS BY REGIONS

4.1 EMEA Anticoagulants Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Anticoagulants Sales by Regions (2012-2017)
  4.1.2 EMEA Anticoagulants Revenue by Regions (2012-2017)
4.2 Europe Anticoagulants Sales and Growth (2012-2017)
4.3 Middle East Anticoagulants Sales and Growth (2012-2017)
4.4 Africa Anticoagulants Sales and Growth (2012-2017)

5 EUROPE ANTICOAGULANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Anticoagulants Sales, Revenue and Market Share by Countries
  5.1.1 Europe Anticoagulants Sales by Countries (2012-2017)
  5.1.2 Europe Anticoagulants Revenue by Countries (2012-2017)
  5.1.3 Germany Anticoagulants Sales and Growth (2012-2017)
  5.1.4 France Anticoagulants Sales and Growth (2012-2017)
  5.1.5 UK Anticoagulants Sales and Growth (2012-2017)
  5.1.6 Russia Anticoagulants Sales and Growth (2012-2017)
  5.1.7 Italy Anticoagulants Sales and Growth (2012-2017)
  5.1.8 Turkey Anticoagulants Sales and Growth (2012-2017)
5.2 Europe Anticoagulants Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Anticoagulants Sales by Manufacturers (2016-2017)
  5.2.2 Europe Anticoagulants Revenue by Manufacturers (2016-2017)
5.3 Europe Anticoagulants Sales by Type (2012-2017)
5.4 Europe Anticoagulants Sales by Application (2012-2017)

6 MIDDLE EAST ANTICOAGULANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Anticoagulants Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Anticoagulants Sales by Countries (2012-2017)
  6.1.2 Middle East Anticoagulants Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Anticoagulants Sales and Growth (2012-2017)
  6.1.4 Israel Anticoagulants Sales and Growth (2012-2017)
  6.1.5 UAE Anticoagulants Sales and Growth (2012-2017)
  6.1.6 Iran Anticoagulants Sales and Growth (2012-2017)
6.2 Middle East Anticoagulants Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Anticoagulants Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Anticoagulants Revenue by Manufacturers (2016-2017)
6.3 Middle East Anticoagulants Sales by Type (2012-2017)
6.4 Middle East Anticoagulants Sales by Application (2012-2017)

7 AFRICA ANTICOAGULANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Anticoagulants Sales, Revenue and Market Share by Countries
  7.1.1 Africa Anticoagulants Sales by Countries (2012-2017)
  7.1.2 Africa Anticoagulants Revenue by Countries (2012-2017)
  7.1.3 South Africa Anticoagulants Sales and Growth (2012-2017)
  7.1.4 Nigeria Anticoagulants Sales and Growth (2012-2017)
  7.1.5 Egypt Anticoagulants Sales and Growth (2012-2017)
  7.1.6 Algeria Anticoagulants Sales and Growth (2012-2017)
7.2 Middle East Anticoagulants Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Anticoagulants Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Anticoagulants Revenue by Manufacturers (2016-2017)
7.3 Middle East Anticoagulants Sales by Type (2012-2017)
7.4 Middle East Anticoagulants Sales by Application (2012-2017)

8 EMEA ANTICOAGULANTS MARKET SEGMENT BY TYPE

8.1 EMEA Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Anticoagulants Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Anticoagulants Revenue and Market Share by Type (2012-2017)
8.2 Platelet aggregation inhibitors (PAI) Sales Growth and Price
  10.2.1 EMEA Platelet aggregation inhibitors (PAI) Sales Growth (2012-2017)
  10.2.2 EMEA Platelet aggregation inhibitors (PAI) Price (2012-2017)
8.3 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
  10.3.1 EMEA Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
  10.3.2 EMEA Low-molecular-weight Heparin (LMWH) Price (2012-2017)
8.4 Direct thrombin inhibitor (DTI) Sales Growth and Price
  10.4.1 EMEA Direct thrombin inhibitor (DTI) Sales Growth (2012-2017)
  10.4.2 EMEA Direct thrombin inhibitor (DTI) Price (2012-2017)
8.5 Direct factor Xa inhibitors (DFXa) Sales Growth and Price
  10.5.1 EMEA Direct factor Xa inhibitors (DFXa) Sales Growth (2012-2017)
  10.5.2 EMEA Direct factor Xa inhibitors (DFXa) Price (2012-2017)
8.6 Vitamin K antagonists (VKA) Sales Growth and Price
  10.6.1 EMEA Vitamin K antagonists (VKA) Sales Growth (2012-2017)
  10.6.2 EMEA Vitamin K antagonists (VKA) Price (2012-2017)
8.7 Others Sales Growth and Price
  10.7.1 EMEA Others Sales Growth (2012-2017)
  10.7.2 EMEA Others Price (2012-2017)

9 EMEA ANTICOAGULANTS MARKET SEGMENT BY APPLICATION

9.1 EMEA Anticoagulants Sales Market Share by Application (2012-2017)
9.2 VTE Sales Growth (2012-2017)
9.3 ACS/MI Sales Growth (2012-2017)
9.4 AF Sales Growth (2012-2017)
9.5 Other Sales Growth (2012-2017)

10 EMEA ANTICOAGULANTS MARKET FORECAST (2017-2022)

10.1 EMEA Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
10.2 Anticoagulants Market Forecast by Regions (2017-2022)
  10.2.1 Europe Anticoagulants Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Anticoagulants Sales Forecast 2017-2022
    10.2.1.2 France Anticoagulants Sales Forecast 2017-2022
    10.2.1.3 UK Anticoagulants Sales Forecast 2017-2022
    10.2.1.4 Russia Anticoagulants Sales Forecast 2017-2022
    10.2.1.5 Italy Anticoagulants Sales Forecast 2017-2022
    10.2.1.6 Turkey Anticoagulants Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Anticoagulants Sales Forecast 2017-2022
    10.2.2.2 Israel Anticoagulants Sales Forecast 2017-2022
    10.2.2.3 UAE Anticoagulants Sales Forecast 2017-2022
    10.2.2.4 Iran Anticoagulants Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Anticoagulants Sales Forecast 2017-2022
    10.2.3.2 Nigeria Anticoagulants Sales Forecast 2017-2022
    10.2.3.3 Egypt Anticoagulants Sales Forecast 2017-2022
    10.2.3.4 Algeria Anticoagulants Sales Forecast 2017-2022
10.3 Anticoagulants Market Forecast by Type (2017-2022)
10.4 Anticoagulants Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Anticoagulants Picture
Table Product Specifications of Anticoagulants
Figure EMEA Sales Market Share of Anticoagulants by Types in 2016
Table Anticoagulants Types for Major Manufacturers
Figure Platelet aggregation inhibitors (PAI) Picture
Figure Low-molecular-weight Heparin (LMWH) Picture
Figure Direct thrombin inhibitor (DTI) Picture
Figure Direct factor Xa inhibitors (DFXa) Picture
Figure Vitamin K antagonists (VKA) Picture
Figure Others Picture
Table Anticoagulants Sales Market Share by Applications in 2016
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure Germany Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure France Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure UK Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Anticoagulants Revenue (Value) and Growth Rate (2012-2022)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Anticoagulants Type and Applications
Table Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Anticoagulants Type and Applications
Table Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Anticoagulants Type and Applications
Table Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Anticoagulants Type and Applications
Table Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Anticoagulants Type and Applications
Table Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Anticoagulants Type and Applications
Table AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Anticoagulants Type and Applications
Table Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Anticoagulants Type and Applications
Table Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lilly Basic Information, Manufacturing Base and Competitors
Table Lilly Anticoagulants Type and Applications
Table Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Anticoagulants Type and Applications
Table Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Anticoagulants Type and Applications
Table Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Anticoagulants Type and Applications
Table Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Anticoagulants Type and Applications
Table The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Anticoagulants Sales by Manufacturer (2016-2017)
Figure EMEA Anticoagulants Sales Market Share by Manufacturer in 2016
Figure EMEA Anticoagulants Sales Market Share by Manufacturer in 2017
Table EMEA Anticoagulants Revenue by Manufacturer (2016-2017)
Figure EMEA Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure EMEA Anticoagulants Revenue Market Share by Manufacturer in 2017
Table EMEA Anticoagulants Price by Manufacturer (2016-2017)
Figure EMEA Anticoagulants Sales and Growth (2012-2017)
Figure EMEA Anticoagulants Revenue and Growth (2012-2017)
Table EMEA Anticoagulants Sales by Regions (2012-2017)
Table EMEA Anticoagulants Sales Market Share by Regions (2012-2017)
Figure EMEA Anticoagulants Sales Market Share by Regions in 2012
Figure EMEA Anticoagulants Sales Market Share by Regions in 2016
Table EMEA Anticoagulants Revenue by Regions (2012-2017)
Table EMEA Anticoagulants Revenue Market Share by Regions (2012-2017)
Figure EMEA Anticoagulants Revenue Market Share by Regions in 2012
Figure EMEA Anticoagulants Revenue Market Share by Regions in 2016
Figure Europe Anticoagulants Sales and Growth (2012-2017)
Figure Middle East Anticoagulants Sales and Growth (2012-2017)
Figure Africa Anticoagulants Sales and Growth (2012-2017)
Figure Europe Anticoagulants Revenue and Growth (2012-2017)
Table Europe Anticoagulants Sales by Countries (2012-2017)
Table Europe Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Europe Anticoagulants Sales Market Share by Countries in 2012
Figure Europe Anticoagulants Sales Market Share by Countries in 2016
Table Europe Anticoagulants Revenue by Countries (2012-2017)
Table Europe Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Europe Anticoagulants Revenue Market Share by Countries in 2012
Figure Europe Anticoagulants Revenue Market Share by Countries in 2016
Figure Germany Anticoagulants Sales and Growth (2012-2017)
Figure France Anticoagulants Sales and Growth (2012-2017)
Figure UK Anticoagulants Sales and Growth (2012-2017)
Figure Russia Anticoagulants Sales and Growth (2012-2017)
Figure Italy Anticoagulants Sales and Growth (2012-2017)
Figure Turkey Anticoagulants Sales and Growth (2012-2017)
Table Europe Anticoagulants Sales by Manufacturer (2016-2017)
Figure Europe Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Europe Anticoagulants Sales Market Share by Manufacturer in 2017
Table Europe Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Europe Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Europe Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Europe Anticoagulants Sales by Type (2012-2017)
Table Europe Anticoagulants Sales Share by Type (2012-2017)
Table Europe Anticoagulants Sales by Application (2012-2017)
Table Europe Anticoagulants Sales Share by Application (2012-2017)
Figure Middle East Anticoagulants Revenue and Growth (2012-2017)
Table Middle East Anticoagulants Sales by Countries (2012-2017)
Table Middle East Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Middle East Anticoagulants Sales Market Share by Countries in 2012
Figure Middle East Anticoagulants Sales Market Share by Countries in 2016
Table Middle East Anticoagulants Revenue by Countries (2012-2017)
Table Middle East Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Middle East Anticoagulants Revenue Market Share by Countries in 2012
Figure Middle East Anticoagulants Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anticoagulants Sales and Growth (2012-2017)
Figure Israel Anticoagulants Sales and Growth (2012-2017)
Figure UAE Anticoagulants Sales and Growth (2012-2017)
Figure Iran Anticoagulants Sales and Growth (2012-2017)
Table Middle East Anticoagulants Sales by Manufacturer (2016-2017)
Figure Middle East Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Middle East Anticoagulants Sales Market Share by Manufacturer in 2017
Table Middle East Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Middle East Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Middle East Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Middle East Anticoagulants Sales by Type (2012-2017)
Table Middle East Anticoagulants Sales Share by Type (2012-2017)
Table Middle East Anticoagulants Sales by Application (2012-2017)
Table Middle East Anticoagulants Sales Share by Application (2012-2017)
Figure Africa Anticoagulants Revenue and Growth (2012-2017)
Table Africa Anticoagulants Sales by Countries (2012-2017)
Table Africa Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Africa Anticoagulants Sales Market Share by Countries in 2012
Figure Africa Anticoagulants Sales Market Share by Countries in 2016
Table Africa Anticoagulants Revenue by Countries (2012-2017)
Table Africa Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Africa Anticoagulants Revenue Market Share by Countries in 2012
Figure Africa Anticoagulants Revenue Market Share by Countries in 2016
Figure South Africa Anticoagulants Sales and Growth (2012-2017)
Figure Nigeria Anticoagulants Sales and Growth (2012-2017)
Figure Egypt Anticoagulants Sales and Growth (2012-2017)
Figure Algeria Anticoagulants Sales and Growth (2012-2017)
Table Middle East Anticoagulants Sales by Manufacturer (2016-2017)
Figure Middle East Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Middle East Anticoagulants Sales Market Share by Manufacturer in 2017
Table Middle East Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Middle East Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Middle East Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Middle East Anticoagulants Sales by Type (2012-2017)
Table Middle East Anticoagulants Sales Share by Type (2012-2017)
Table Middle East Anticoagulants Sales by Application (2012-2017)
Table Middle East Anticoagulants Sales Share by Application (2012-2017)
Table EMEA Anticoagulants Sales by Type (2012-2017)
Table EMEA Anticoagulants Sales Share by Type (2012-2017)
Table EMEA Anticoagulants Revenue by Type (2012-2017)
Table EMEA Anticoagulants Revenue Share by Type (2012-2017)
Figure EMEA Platelet aggregation inhibitors (PAI) Sales Growth (2012-2017)
Figure EMEA Platelet aggregation inhibitors (PAI) Price (2012-2017)
Figure EMEA Low-molecular-weight Heparin (LMWH) Sales Growth (2012-2017)
Figure EMEA Low-molecular-weight Heparin (LMWH) Price (2012-2017)
Figure EMEA Direct thrombin inhibitor (DTI) Sales Growth (2012-2017)
Figure EMEA Direct thrombin inhibitor (DTI) Price (2012-2017)
Figure EMEA Direct factor Xa inhibitors (DFXa) Sales Growth (2012-2017)
Figure EMEA Direct factor Xa inhibitors (DFXa) Price (2012-2017)
Figure EMEA Vitamin K antagonists (VKA) Sales Growth (2012-2017)
Figure EMEA Vitamin K antagonists (VKA) Price (2012-2017)
Figure EMEA Others Sales Growth (2012-2017)
Figure EMEA Others Price (2012-2017)
Table EMEA Anticoagulants Sales by Application (2012-2017)
Table EMEA Anticoagulants Sales Share by Application (2012-2017)
Figure EMEA VTE Sales Growth (2012-2017)
Figure EMEA ACS/MI Sales Growth (2012-2017)
Figure EMEA AF Sales Growth (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Anticoagulants Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Anticoagulants Sales Forecast by Regions (2017-2022)
Table EMEA Anticoagulants Market Share Forecast by Regions (2017-2022)
Table Europe Anticoagulants Sales Forecast by Regions (2017-2022)
Figure Germany Anticoagulants Sales Forecast 2017-2022
Figure France Anticoagulants Sales Forecast 2017-2022
Figure UK Anticoagulants Sales Forecast 2017-2022
Figure Russia Anticoagulants Sales Forecast 2017-2022
Figure Italy Anticoagulants Sales Forecast 2017-2022
Figure Turkey Anticoagulants Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Anticoagulants Sales Forecast 2017-2022
Figure Israel Anticoagulants Sales Forecast 2017-2022
Figure UAE Anticoagulants Sales Forecast 2017-2022
Figure Iran Anticoagulants Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Anticoagulants Sales Forecast 2017-2022
Figure Nigeria Anticoagulants Sales Forecast 2017-2022
Figure Egypt Anticoagulants Sales Forecast 2017-2022
Figure Algeria Anticoagulants Sales Forecast 2017-2022
Table EMEA Anticoagulants Sales Forecast by Type (2017-2022)
Table EMEA Anticoagulants Market Share Forecast by Type (2017-2022)
Table EMEA Anticoagulants Sales Forecast by Application (2017-2022)
Table EMEA Anticoagulants Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
Figure Europe Others Sales Growth (2012-2017)
Figure Europe Others Price (2012-2017)